BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Drug Development

  Inovio Pharma’s Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses In Tumor Tissue And Peripheral Blood In Patients With HPV-Associated Head And Neck Cancer

  November 14, 2016

   · 

  7 min read
• FDA

  Amgen Release: European Commission (EC) Approves Parsabiv (etelcalcetide) For The Treatment Of Secondary Hyperparathyroidism In Adults On Hemodialysis

  November 14, 2016

   · 

  13 min read
• Drug Development

  OncoSec Medical Presents Positive Interim Response Data At The Society For Immunotherapy Of Cancer (SITC) Annual Meeting 2016

  November 14, 2016

   · 

  4 min read
• Nabriva Announces Planned Rights Offering And Sets Record Date

  November 14, 2016

   · 

  3 min read
• Pharm Country

  Canon BioMedical Launches The Novallele Control Set

  November 14, 2016

   · 

  2 min read
• Business

  iSpecimen And TriCore Reference Laboratories Announce Collaboration To Make Human Biospecimens And Data Available For Research

  November 14, 2016

   · 

  3 min read
• Policy

  Novartis AG Drug PKC412 (Midostaurin) Granted FDA Priority Review For Newly-Diagnosed FLT3-Mutated AML And Advanced Systemic Mastocytosis

  November 14, 2016

   · 

  12 min read
• Business

  Integrity Applications Incorporated Release: GlucoTrack Maker Names Two New Board Members

  November 14, 2016

   · 

  5 min read
• FDA

  FDA Clears CapsoVision’s CapsoCam Plus

  November 14, 2016

   · 

  3 min read
• Drug Development

  Idera Pharma Reports Translational Data Supporting The Mechanism Of Action Of Intratumoral IMO-2125 From Ongoing Phase I Dose Escalation In Clinical Trial In Combination With Ipilimumab In Metastatic Melanoma Patients Refractory To Anti-PD-1 Treatment

  November 14, 2016

   · 

  9 min read